Correlation Between NLS Pharmaceutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on NLS Pharmaceutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Pasithea Therapeutics.
Diversification Opportunities for NLS Pharmaceutics and Pasithea Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between NLS and Pasithea is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Pasithea Therapeutics
Assuming the 90 days horizon NLS Pharmaceutics AG is expected to generate 4.79 times more return on investment than Pasithea Therapeutics. However, NLS Pharmaceutics is 4.79 times more volatile than Pasithea Therapeutics Corp. It trades about 0.03 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.05 per unit of risk. If you would invest 1.50 in NLS Pharmaceutics AG on August 30, 2024 and sell it today you would lose (0.46) from holding NLS Pharmaceutics AG or give up 30.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 54.55% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| NLS Pharmaceutics |
| Pasithea Therapeutics |
NLS Pharmaceutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Pasithea Therapeutics
The main advantage of trading using opposite NLS Pharmaceutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
| Pasithea Therapeutics vs. Pasithea Therapeutics Corp | Pasithea Therapeutics vs. Biofrontera Warrants | Pasithea Therapeutics vs. Lixte Biotechnology Holdings | Pasithea Therapeutics vs. Jasper Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |